摘要
目的探讨分析PDCA循环管理法对COPD患者正确使用信必可-都保的临床治疗效果。方法本研究选取2015年1月至2016年12月106例在我院就诊的COPD患者作为研究对象,随机分为观察组和对照组各53例,对照组患者采用常规护理指导,观察组患者采用PDCA循环管理法指导用药,分析比较两组患者肺功能指标恢复、总体满意度及信必可-都保的正确使用率。结果护理后,两组患者FEV1、FVC、FEV1/FVC%指标均显著升高,且观察组患者升高程度更明显,差异有统计学意义(P<0.05)。观察组患者护理总满意率58.49%,显著高于对照组患者护理总满意率32.08%,差异有统计学意义(Z=-1.895,P=0.041)。观察组患者信必可-都保正确使用率88.68%(47/53),显著高于对照组患者60.38%(32/53),差异有统计学意义(χ2=11.180,P=0.001)。结论 PDCA循环管理法能显著提高COPD患者信必可-都保正确使用率,显著改善患者肺功能、患者满意度高,临床疗效显著。
Objective To explore the clinical efficacy of PDCA cycle management on the proper use of Symbicort Turbuhaler in treatment of COPD patients with. Methods This study included 106 COPD patients those who went our hospital during January 2016 and December 2017,and they were randomly divided into observation group and control group and 53 cases in each group. Using conventional nursing guidance and PDCA cycle management method to guide the medication,pulmonary function recovery,overall satisfaction and the correct use symbicort turbuhaler of the two groups were compared. Results All the indicators including FEV1,FVC,and FEV1/FVC% were increased obviously,and the increase in observation group were significantly better in the observation group than in the control group（ P〈0. 05）; The overall satisfaction of the patients in the observation group（ 58.49%） was significantly higher than that in the control group（ 32.08%）,the difference was statistically significant（ Z =-1.895,P = 0.041）; The correct use of symbicort turbuhaler in the observation group88.68%（ 47/53） was significantly higher than that in the control group 60.38%（ 32/53）（ χ^2= 11.180,P = 0.001）.Conclusions PDCA cycle management law can significantly improve the correct use rate of symbicort turbuhaler in COPD patients,significantly improve the patient＇s lung function,promote patient symptoms,clinical efficacy is significant.
出处
《齐齐哈尔医学院学报》
2017年第17期2080-2081,共2页
Journal of Qiqihar Medical University
